Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys

被引:25
|
作者
Marti-Pastor, Marc [1 ,2 ,3 ]
Pont, Angels [1 ,2 ]
Avila, Monica [1 ,2 ,4 ]
Garin, Olatz [1 ,2 ,4 ]
Vilagut, Gemma [1 ,2 ,4 ]
Forero, Carlos G. [1 ,2 ,4 ]
Pardo, Yolanda [1 ,2 ,3 ]
Tresserras, Ricard [4 ,5 ]
Medina-Bustos, Antonia [5 ]
Garcia-Codina, Oriol [5 ]
Cabases, Juan [6 ]
Rajmil, Luis [1 ,2 ,7 ]
Alonso, Jordi [1 ,2 ,4 ]
Ferrer, Montse [1 ,2 ,3 ]
机构
[1] IMIM Hosp Mar Med Res Inst, Hlth Serv Res Grp, Doctor Aiguader 88, Barcelona 08003, Spain
[2] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
[3] Univ Autonoma Barcelona, Barcelona, Spain
[4] Univ Pompeu Fabra, Barcelona, Spain
[5] Dept Salut Gen Catalunya, Direccio Gen Planificacio Salut, Barcelona, Spain
[6] Univ Publ Navarra, Pamplona, Spain
[7] Agcy Healthcare Qual & Assessment Catalonia AQuAS, Barcelona, Spain
来源
POPULATION HEALTH METRICS | 2018年 / 16卷
关键词
Quality of life; Health survey; Validity and reliability; Perceived health; QUALITY-OF-LIFE; CANCER-PATIENTS; OUTCOME MEASURES; 5-LEVEL VERSION; UNITED-KINGDOM; STANDARD EQ-5D; PATIENT GROUPS; RESPONSIVENESS; INSTRUMENTS; VALIDITY;
D O I
10.1186/s12963-018-0170-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The EQ-5D has been frequently used in national health surveys. This study is a head-to-head comparison to assess how expanding the number of levels from three (EQ-5D-3L) to five in the new EQ-5D-5L version has improved its distribution, discriminatory power, and validity in the general population. Methods: A representative sample (N = 7554) from the Catalan Health Interview Survey 2011-2012, aged >= 18, answered both EQ-5D versions, and we evaluated the response redistribution and inconsistencies between them. To assess validity of this redistribution, we calculated the mean of the Visual Analogue Scale (VAS), which measures perceived health. The discriminatory power was examined with Shannon Indices, calculated for each dimension separately. Spanish preference value sets were applied to obtain utility indices, examining their distribution with statistics of central tendency and dispersion. We estimated the proportion of individuals reporting the best health state in EQ-5D-5L and EQ-5D-3L within groups of specific chronic conditions and their VAS mean. Results: A very small reduction in the percentage of individuals with the best health state was observed, from 61.8% in EQ-5D-3L to 60.8% in EQ-5D-5L. In contrast, a large proportion of individuals reporting extreme problems in the 3 L version moved to severe problems (level 4) in the 5 L version, particularly for pain/discomfort (75.5%) and anxiety/depression (66.4%). The average proportion of inconsistencies was 0.9%. The pattern of the perceived health VAS mean confirmed the hypothesis established a priori, supporting the validity of the observed redistribution. Shannon index showed that absolute informativity was higher in the 5 L version for all dimensions. The means (SD) of the Spanish EQ5D- 3L and EQ-5D-5L indices were 0.87 (0.25) and 0.89 (0.22). The proportion of individuals with the best health state within each specific chronic condition was very similar, regardless of the EQ-5D version (<= 30% in half of the 28 chronic conditions). Conclusion: Although the proportion of individuals with the best possible health state is still very high, our findings support that the increase of levels provided by the EQ-5D-5L contributed to the validity and discriminatory power of this new version to measure health in general population, as in the national health surveys.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys
    Marc Martí-Pastor
    Angels Pont
    Mónica Ávila
    Olatz Garin
    Gemma Vilagut
    Carlos G. Forero
    Yolanda Pardo
    Ricard Tresserras
    Antonia Medina-Bustos
    Oriol Garcia-Codina
    Juan Cabasés
    Luis Rajmil
    Jordi Alonso
    Montse Ferrer
    Population Health Metrics, 16
  • [2] Is EQ-5D-5L better over time? A head-to-head comparison of responsiveness of the EQ-5D-3L and EQ-5D-5L
    Buchholz, Ines
    Janssen, Mathieu
    Golicki, Dominik
    Bonsel, Gouke
    QUALITY OF LIFE RESEARCH, 2019, 28 : S163 - S163
  • [3] COMPARISON BETWEEN THE EQ-5D-5L AND THE EQ-5D-3L FOR GENERAL POPULATION IN CHINA
    Zhou, T.
    Guan, H. J.
    Ma, A.
    Liu, G. G.
    VALUE IN HEALTH, 2016, 19 (07) : A829 - A829
  • [4] A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients
    Hongjuan Yu
    Xueyun Zeng
    Mingjie Sui
    Rui Liu
    Rachel Lee-Yin Tan
    Jinjin Yang
    Weidong Huang
    Nan Luo
    Quality of Life Research, 2021, 30 : 855 - 866
  • [5] A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients
    Yu, Hongjuan
    Zeng, Xueyun
    Sui, Mingjie
    Liu, Rui
    Tan, Rachel Lee-Yin
    Yang, Jinjin
    Huang, Weidong
    Luo, Nan
    QUALITY OF LIFE RESEARCH, 2021, 30 (03) : 855 - 866
  • [6] COMPARING EQ-5D-3L AND EQ-5D-5L IN A GENERAL POPULATION
    Ferreira, L. N.
    Ferreira, P. L.
    Pereira, L. N.
    Antunes, P.
    VALUE IN HEALTH, 2016, 19 (07) : A477 - A477
  • [7] A Comparison of the EQ-5D-3L and EQ-5D-5L
    Alexander James Thompson
    Alex James Turner
    PharmacoEconomics, 2020, 38 : 575 - 591
  • [8] A Comparison of the EQ-5D-3L and EQ-5D-5L
    Thompson, Alexander James
    Turner, Alex James
    PHARMACOECONOMICS, 2020, 38 (06) : 575 - 591
  • [9] A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients
    Huan Zhang
    Bo Liu
    Wen Gu
    Yiyin Cao
    Juan Xu
    Rachel Lee-Yin Tan
    Enxue Chang
    Wanji Zheng
    Haofei Li
    Lan Zhou
    Yanni Jia
    Hongbin Yang
    Sheng Guo
    Weidong Huang
    Nan Luo
    Supportive Care in Cancer, 2024, 32
  • [10] A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients
    Zhang, Huan
    Liu, Bo
    Gu, Wen
    Cao, Yiyin
    Xu, Juan
    Tan, Rachel Lee-Yin
    Chang, Enxue
    Zheng, Wanji
    Li, Haofei
    Zhou, Lan
    Jia, Yanni
    Yang, Hongbin
    Guo, Sheng
    Huang, Weidong
    Luo, Nan
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)